Vidwan-ID : 61110



  • Prof Mohd. Aqil

  • Professor
  • Jamia Hamdard
Publications 2002 - 2022

Publications

  • 166
    Journal Articles
  • 6
    Book Chapter
  • 2
    Conference
    Proceedings
  • 27
    Review
  • 4
    Letter
  • 1
    Editorial
  • 1
    Note
  • 1
    Short Survey
  • 3
    Projects
  • 14
  • 9
  • 19
  • 122

Citations / H-Index

6568 Citations
42 h-index
5374 Citations

Altmetrics

56
66
52
3020
42

Google Scholar

Co-author Network


Expertise

Pharmacology and Pharmacy

Phamaceutics

Personal Information

Prof Mohd. Aqil

Male
Department of Phamaceutics, Jamia Hamdard University Jamia Hamdard, Hamdard Nagar
South Delhi, Delhi, India - 110062


Experience

  • Professor

    Department of Pharmaceutics

    Jamia Hamdard


Qualification

  • Ph.D

    Jamia Hamdard University


Honours and Awards

2023

National Award for Excellence in Education 2023

AMP. Mumbai

2012

UGC Research Award 2012-14

UGC

2008

BOYSCAST Fellowship

DST

Read More
2023

National Award for Excellence in Education 2023

AMP. Mumbai

2012

UGC Research Award 2012-14

UGC

2008

BOYSCAST Fellowship

DST

2006

Young Muslim Scientist Award

MAAS, Aligarh

2006

Visiting Scientist to UK

INSA and Royal Society, UK

Read Less

Doctoral Theses Guided

2023

Amelioration of skin cancer by apigenin based nanocarrier gel

Ayesha Waheed , Jamia Hamdard

2021

Polyherbal nanogel for management of psoriasis

Abdul Qadir , Jamia Hamdard

2019

Nanocarrier based transdermal drug delivery system of fisetin for management of skin cancer

Thasleem M., Jamia Hamdard

Read More
2023

Amelioration of skin cancer by apigenin based nanocarrier gel

Ayesha Waheed , Jamia Hamdard

2021

Polyherbal nanogel for management of psoriasis

Abdul Qadir , Jamia Hamdard

2019

Nanocarrier based transdermal drug delivery system of fisetin for management of skin cancer

Thasleem M., Jamia Hamdard

2016

Particulate and vesicular drug delivery systems of an atypical antipsychotic agent for management of schizophrenia

Syed Sarim Imam, Jamia Hamdard

2015

Novel vesicular drug delivery systems for management of Alzheimerā€™s disease

Atefeh Afshar Moghaddam, Jamia Hamdard

2011

Novel penetration enhancer based transdermal drug delivery systems for management of hypertension

Abdul Ahad, Jamia Hamdard

2011

Novel hydrogel based ocular drug delivery systems

Himanshu Gupta, Jamia Hamdard

2010

Nanoemulsion based transdermal therapeutic system for management of hypertension

Md. Rizwan, Jamia Hamdard

2009

Development and evaluation of an oral controlled release osmotic formulation of trimetazidine hydrochloride

Md. Naushad Alam , Jamia Hamdard

Read Less

Membership In Professional Bodies

2015

Indian Science Congress Association (L20905)

Life Member

2008

Association of Pharmaceutical Teachers of India (ND/LM-008)

Life Member

1999

Indian Pharmaceutical Association ( DLH/LM/0250)

Life member

2015

Indian Science Congress Association (L20905)

Life Member

2008

Association of Pharmaceutical Teachers of India (ND/LM-008)

Life Member

1999

Indian Pharmaceutical Association ( DLH/LM/0250)

Life member

Read Less

Membership In Committees

2017

M. Pharm. Program Committee

Member

2017

M. Pharm. Program Committee

Member

Read Less

Research Projects

Formulation and characterization of nanoemulsion based transdermal therapeutic systems for management of hypertension

Funding Agency : UGC

Development and evaluation of novel penetration enhancer based transdermal drug delivery systems for management of hypertension

Funding Agency : AICTE

Development and evaluation of transdermal drug delivery systems of an antihypertensive drug

Funding Agency : DST

Formulation and characterization of nanoemulsion based transdermal therapeutic systems for management of hypertension

Funding Agency : UGC

Development and evaluation of novel penetration enhancer based transdermal drug delivery systems for management of hypertension

Funding Agency : AICTE

Development and evaluation of transdermal drug delivery systems of an antihypertensive drug

Funding Agency : DST

Read Less

Patents







Read Less